• About ENEAAbout ENEA
  • Committees
  • Standing Office
  • Prizes
  • Bylaws
  • ENEA Young Researcher Committee
ENEA-logo-RVBENEA-logo-RVB
  • Home
  • Latest News
  • Congresses & Workshops
  • About ENEA
    • Committees
    • Standing Office
    • Prizes
    • Bylaws
    • EYRC
  • Sponsors
  • EYRC
  • Membership
  • Contact
  • RESOURCES
    • Newsletters
    • ENEA registry
    • ENEA publications
    • Education – CME
    • Guidelines
  • My Account
    • Registration
ENEA-logo-RVB
ENEA-logo-RVB

Prolactinoma study

22 December 2022Patrick Petrossians

Secondary end-points:

  1. Definition ‘resistant prolactinomas’
  2. Assessment of current management
  3. Database on resistant prolactinomas

We thank the 7 sites that have already registered patients:

  • National and Kapodistrian University of Athens – GREECE – 3 cases
  • Vall d’Hebron- Barcelona – SPAIN – 6 cases
  • University Clinical Centre of Serbia- Belgrade – SERBIA – 10 cases
  • University Hospital Centre Zagreb- Zagreb – CROATIA – 9 cases
  • MONIKI M.F. Vladimirskii Moscow Regional Scientific Research Institute & Almazov National Medical Research Centre – RUSSIA – 9 cases
  • University of Naples – Federico II – ITALY – 1 case

All our members are invited to participate till the recruitment of 600 patients.
Thank you very much in advance for your participation In the PROLACTINOMA STUDY
Dr Krystallenia Alexandraki, alexandrakik@gmail.com

https://www.synergy2go.com/index.php

You must be logged in to post a comment.

Follow us on Twitter & Linkedin

Twitter
LinkedIn
Data PrivacyMy AccountContact
© 2020 All rights reserved.